Pharmaceutical
(+)-Dibenzoyl-D-tartaric acid monodimethylamide
Technical characteristics
(+)-Dibenzoyl-D-tartaric acid monodimethylamideCas N°36624-61-0
C20H19N1O7
P
Molecular Weight: 385,37663
-Dibenzoyl-D-tartaric acid monodimethylamide.jpg)
Our location
CDMO Lahr
Germany
Address
Uetikon, Raiffeisenstraße 4
77933 Lahr
77933 Lahr
Business Line
Custom Manufacturing, APIs & Intermediates
Phone
49 7821 585 0
Market
Pharmaceutical
Email
info@uetikon.com
More information
Surface: 48, 000 m²
Lab surface: 700 m²
Capabilities:
- Total reactor capacity: 92 m³
- Reaction vessels: 1 to 6 300 L; temperature -80°C to +250 °C
- Multi-purpose state of the art cGMP facilty: 4 independent, vertical integrated production trains 800 L train, 2 x 3 000 L trains plus 1 x 3 000 L low temperature hydrogenation reactor and 6 000 L train
- Classic two-floor layout Facility: 20 vessels with capacity between 800 and 6 000 L (glaslined and SS)
- Autoclaves (operational range up to 100 bar)
- Kilo-Lab: 3 reactors: 25 / 100 / 250 L
Flagship technologies:
- Hydrogenation
- Reductive amination
- Organometallic reactions
- Protected AADs (Aminoacid derivatives)
- Carbonylation & Hydroformylation
- Pressure aminolysis, other reactions under pressure
- Cryogenic chemistry
- Enantiopure synthesis
- Cyanation high volumes (NaCN) C-C coupling
- Reductions
- Halogenation
Number of scientists: 25
Last inspections:
- FDA 2018
- The last inspection by the authorities took place on the 23rd November 2021 / Die letzte Inspektion der Aufsichtsbehörde fand am 23.11.2021 statt.
Certifications:
- GMP
- ISO 9001
- ISO 50001
Seveso regulation – Information for the public / Störfallverordnung – Information der Öffentlichkeit
EcoVadis CSR Rating: Gold Certification